Tim Watkins
CMO & Head of Development · Contineum Therapeutics, Inc.
- 2026
- Jul 1, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Tim Watkins files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel S. Lorrain - $1.04M in CTNM purchases and sales in the last 12 months
- Carmine N. Stengone - $401K in CTNM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Tim Watkins?
Tim Watkins is a corporate insider, tracked as CMO & Head of Development of Contineum Therapeutics, Inc. (CTNM). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Tim Watkins last file a Form 4?
The most recent primary Form 4 on record is dated 1 July 2026, one of 3 filings going back to 2026.
Has Tim Watkins been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($279K) across all tracked filings.
